IPHA Message Board Post 10038012 | Innate Pharma S.A.
home / stock / ipha / ipha message board
psmolsky
(investorshub)
Posted on: Sep/03/2021 17:48:03
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165769910
$IPHA: LETSSSSSSSSSS GOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
News, Short Squeeze, Breakout and More Instantly...
-
Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “ AMF ”) General Regulation, Innate Pharma SA (Euronext Pari...
-
SAR443579/IPH6101, ANKET ® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between Innate Pharma and Sanofi, under development by Sanofi in R/R AML, B-ALL and HR-MDS SAR443579/IPH6101 continues ...
-
In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety profile consistent with prior studies. Innate will host a virtual KOL...